Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Non-small-cell lung cancer (NSCLC) is the most common form of lung cancer and a leading cause of cancer mortality globally.
• Current treatments for NSCLC often face challenges due to poor prognosis and resistance to conventional therapies like radiation and chemotherapy.
• The molecular mechanisms underlying NSCLC progression require further investigation to develop more effective treatments.

Purpose of the Study:

• To review recent advances in understanding the relationship between autophagy and apoptosis in NSCLC.
• To explore the complex interplay and crosstalk between these two cellular processes in NSCLC pathophysiology.
• To provide insights for identifying novel pathogenic factors and developing new therapeutic strategies for NSCLC.

Main Methods:

• Literature review of recent scientific publications on autophagy, apoptosis, and NSCLC.
• Analysis of signaling pathways and protein interactions involved in both autophagy and apoptosis in the context of NSCLC.
• Synthesis of current knowledge on the dual role of autophagy in NSCLC (inhibitory and stimulatory effects on apoptosis).

Main Results:

• Autophagy and apoptosis are critical cellular processes implicated in NSCLC.
• The relationship between autophagy and apoptosis in NSCLC is complex and bidirectional, with reported inhibitory and stimulatory effects of autophagy on apoptosis.
• Significant crosstalk exists between proteins that regulate both autophagy and apoptosis, influencing NSCLC progression.

Conclusions:

• The intricate relationship between autophagy and apoptosis plays a crucial role in NSCLC.
• Further research into the molecular mechanisms governing autophagy-apoptosis interplay may reveal novel therapeutic targets.
• Elucidating these pathways could lead to the development of more efficacious treatments for non-small-cell lung cancer.